论文信息 - Abstract CT151: A Phase II study of NLG207 (formerly CRLX101) in combination with weekly paclitaxel in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancer - 字舞流文

Abstract CT151: A Phase II study of NLG207 (formerly CRLX101) in combination with weekly paclitaxel in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancer

P. Thaker | C. Link | Austin Miller | R. Schilder | L. Duska | E. Kennedy | D. O’Malley | C. Mathews | C. Krasner | N. Vahanian | L. Tennant | Christopher M Smith | K. Moore | D. Mercier | C. Purdy | A. J. Leyco